China Shineway Pharmaceutical Group Limited (FRA:C1S)
Germany flag Germany · Delayed Price · Currency is EUR
0.7950
-0.0150 (-1.85%)
At close: May 9, 2025, 10:00 PM CET

FRA:C1S Statistics

Total Valuation

FRA:C1S has a market cap or net worth of EUR 613.78 million. The enterprise value is -132.86 million.

Market Cap 613.78M
Enterprise Value -132.86M

Important Dates

The last earnings date was Friday, May 2, 2025.

Earnings Date May 2, 2025
Ex-Dividend Date Apr 30, 2025

Share Statistics

Current Share Class 755.40M
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 207.04M

Valuation Ratios

The trailing PE ratio is 5.52 and the forward PE ratio is 6.03.

PE Ratio 5.52
Forward PE 6.03
PS Ratio 1.23
PB Ratio 0.62
P/TBV Ratio 0.64
P/FCF Ratio 5.64
P/OCF Ratio 4.82
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.20
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -1.22

Financial Position

The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.05.

Current Ratio 3.51
Quick Ratio 3.17
Debt / Equity 0.05
Debt / EBITDA 0.38
Debt / FCF 0.42
Interest Coverage 136.40

Financial Efficiency

Return on equity (ROE) is 11.59% and return on invested capital (ROIC) is 6.90%.

Return on Equity (ROE) 11.59%
Return on Assets (ROA) 5.33%
Return on Invested Capital (ROIC) 6.90%
Return on Capital Employed (ROCE) 11.01%
Revenue Per Employee 155,265
Profits Per Employee 34,523
Employee Count 3,220
Asset Turnover 0.39
Inventory Turnover 1.11

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -23.83% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -23.83%
50-Day Moving Average 0.92
200-Day Moving Average 0.99
Relative Strength Index (RSI) 33.38
Average Volume (20 Days) 1,216

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:C1S had revenue of EUR 499.95 million and earned 111.17 million in profits. Earnings per share was 0.15.

Revenue 499.95M
Gross Profit 374.73M
Operating Income 110.63M
Pretax Income 151.61M
Net Income 111.17M
EBITDA 117.97M
EBIT 110.63M
Earnings Per Share (EPS) 0.15
Full Income Statement

Balance Sheet

The company has 859.45 million in cash and 45.86 million in debt, giving a net cash position of 813.59 million.

Cash & Cash Equivalents 859.45M
Total Debt 45.86M
Net Cash 813.59M
Net Cash Per Share n/a
Equity (Book Value) 988.11M
Book Value Per Share 1.31
Working Capital 813.64M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 127.45 million and capital expenditures -18.54 million, giving a free cash flow of 108.91 million.

Operating Cash Flow 127.45M
Capital Expenditures -18.54M
Free Cash Flow 108.91M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 74.95%, with operating and profit margins of 22.13% and 22.24%.

Gross Margin 74.95%
Operating Margin 22.13%
Pretax Margin 30.33%
Profit Margin 22.24%
EBITDA Margin 23.60%
EBIT Margin 22.13%
FCF Margin 21.78%

Dividends & Yields

This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 7.05%.

Dividend Per Share 0.06
Dividend Yield 7.05%
Dividend Growth (YoY) -16.93%
Years of Dividend Growth 2
Payout Ratio 48.56%
Buyback Yield n/a
Shareholder Yield 7.05%
Earnings Yield 18.11%
FCF Yield 17.74%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:C1S has an Altman Z-Score of 3.85.

Altman Z-Score 3.85
Piotroski F-Score n/a